“Cognitive enhancement drugs only have short-term benefits and can cause significant side-effects for people with mild memory problems, according to researchers. In a new review of existing data, researchers at St. Michael’s Hospital in Toronto, Canada studied eight randomized clinical trials and three companion reports on the efficacy of four drugs in people with mild cognitive impairment. The drugs were donepezil (Aricept), rivastigmine (Exelon), galantamine (Razadyne), and memantine (Namenda). They found that while the drugs do have short-term benefits, they are lost after a year and a half of treatment.”
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin
Tip Freedomwat.ch Staff with Bitcoin
Related posts:
FDA panel pushing for new limits on access to Vicodin
Shenzhen’s Properties Soar As Foreigners Rush In
U.S. Payroll Tax Will Be Higher in 2013
Bitcoin Coming To Your 401(k)?
Former police officer indicted for stealing $13,000 in DARE donations
Two Japanese airlines to disregard China air zone rules
Who funds Syrian rebel advocate O’Bagy and her 'Task Force'? You do
Russia Today's Editor-In-Chief: 'The West Never Got Over the Cold War Stereotype'
Louisiana police chief indicted on child rape charges
U.S. diplomat warns of global effort to curb Internet freedom
Spy-spotter: joke about scary visit came true
Ben Bernanke Joins Hedge Fund Citadel as an Adviser
Aborted babies incinerated to heat UK hospitals
Jordanians ‘suspicious’ about U.S. troop movements
Toyota tests wireless charging for electric cars